Stephen has over 20 years of finance experience and has a personal relationship to food allergies. He is the director of the KeepSmilin4Abbie Foundation, which is dedicated to preventing food-related anaphylaxis.
Jamie is one of the company's IP attorneys. He has worked with Allergy Amulet since its inception, and was the company's first investor. He has helped Allergy Amulet develop a robust IP strategy and maintain its competitive IP advantage.
Halley is the SVP & Chief Legal Officer of Ironwood Pharmaceuticals and has over 15 years of experience in healthcare and law. She holds a J.D. from Northwestern University and a B.A. from Tufts. Halley has two daughters with severe food allergies.
Dr. John Lee
John is an allergist at Boston Children's Hospital and teaches pediatric courses at Harvard Medical School. Dr. Lee is widely recognized for his work in the food allergy space and his commitment to patient health.
Dr. Sue Long
Sue is a member of the advisory board at North Shore Innoventures. She holds a Ph.D. in microbiology and a post-doctorate in molecular biology from MIT. Dr. Long has over 20 years of professional experience in the pharmaceutical space.
Dr. Bridget Martell
Bridget is the Chief Medical Officer at Juniper Pharmaceuticals and an adjunct professor at the Yale School of Medicine. Dr. Martell has over 15 years of experience in clinical product development and regulatory strategy.
Dr. Mike Morency, JD
Mike advises Allergy Amulet on its IP and legal strategy. Mike received his law degree from the University of Ottawa and his Ph.D. in medical sciences from McCaster University. Dr. Morency's research focused on the pharmacology and molecular biology of dopamine receptors. Mike is a former IP partner at Foley & Lardner, LLP.
Dr. Jordan Scott
Jordan is an allergist-immunologist at Boston Children's Hospital and operates several private allergy clinics throughout the Boston area. Dr. Scott is also a clinical instructor in allergy/immunology at Harvard Medical School and President of the Massachusetts Allergy & Asthma Society.
Chris is the Co-Founder and CEO of Windgap Medical, an epinephrine auto-injector company. He is a seasoned entrepreneur with more than 25 years of experience in operations, finance, strategy, and technology. Chris holds an engineering degree and an M.B.A. from MIT.